Merck Strikes Total $1.7B Collabs With Cancer Biotech Co.
Pharmaceutical giant Merck said Monday that it has teamed up with Fenwick and Cooley-led biotechnology company Seattle Genetics to collaborate on two of its cancer therapies for roughly $1.73 billion, including...To view the full article, register now.
Already a subscriber? Click here to view full article